NECROTISING SCLERITIS

NECROTISING SCLERITIS was reported 145 times

NECROTISING SCLERITIS is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Polyene Antimicrobial [EPC] 6 0.0146
1 Aminoglycoside Antibacterial [EPC] 13 0.0003
2 Photoenhancer [EPC] 1 0.0003
3 Anticholinergic [EPC] 3 0.0002
4 Antimycobacterial [EPC] 2 0.0001
5 Lipid-based Polyene Antifungal [EPC] 1 0.0001
6 Fluoroquinolone Antibacterial [EPC] 10 0.0001
7 Cholinergic Muscarinic Antagonist [EPC] 3 0.0001
8 Alkylating Drug [EPC] 15 0.0001
9 Folate Analog Metabolic Inhibitor [EPC] 25 0.0001
10 Glycopeptide Antibacterial [EPC] 3 0.0000
11 Azole Antifungal [EPC] 7 0.0000
12 Corticosteroid [EPC] 57 0.0000
13 Antirheumatic Agent [EPC] 4 0.0000
14 Provitamin D2 Compound [EPC] 1 0.0000
15 Vitamin D [EPC] 10 0.0000
16 Tumor Necrosis Factor Blocker [EPC] 32 0.0000
17 Vitamin B12 [EPC] 10 0.0000
18 Tetracycline-class Drug [EPC] 2 0.0000
19 Rifamycin Antibacterial [EPC] 1 0.0000
20 Vascular Endothelial Growth Factor Inhibitor [EPC] 5 0.0000
21 Vitamin C [EPC] 11 0.0000
22 Polyene Antifungal [EPC] 1 0.0000
23 Calcineurin Inhibitor Immunosuppressant [EPC] 3 0.0000
24 Purine Antimetabolite [EPC] 2 0.0000
25 Aminosalicylate [EPC] 2 0.0000
26 Macrolide Antimicrobial [EPC] 1 0.0000
27 Platinum-based Drug [EPC] 5 0.0000
28 Interleukin-6 Receptor Antagonist [EPC] 2 0.0000
29 Integrin Receptor Antagonist [EPC] 1 0.0000
30 Prostaglandin Analog [EPC] 1 0.0000
31 CD20-directed Cytolytic Antibody [EPC] 3 0.0000
32 Aromatase Inhibitor [EPC] 1 0.0000
33 Histamine-2 Receptor Antagonist [EPC] 1 0.0000
34 Nucleoside Metabolic Inhibitor [EPC] 2 0.0000
35 Nonsteroidal Anti-inflammatory Drug [EPC] 9 0.0000
36 Janus Kinase Inhibitor [EPC] 1 0.0000
37 Angiotensin 2 Receptor Blocker [EPC] 1 0.0000
38 Platelet Aggregation Inhibitor [EPC] 1 0.0000